Correlates of Fatigue in People With Schizophrenia
- Disease/Condition
- Schizophrenia
- Drug/Device/Intervention
- Assessment of potential fatigue factors
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- GCS CIPS
- Phase
- N/A
- Start date
- May 01, 2024
- End date
- Aug 01, 2025
- Enrollment
- 61 participants
Strength of predictive model of fatigue in schizophrenia
The goal of this experimental prospective study is to build an explicative model of trait
 fatigue in adults with schizophrenia engaged in a psychosocial rehabilitation process.
 
 The main questions it aims to answer are:
 
 - Which factors amongst those evaluated explain the most of fatigue variance in people
 with schizophrenia?
 
 - Which clinical factors characterise the most fatigued participants compared to less
 fatigued participants?
 
 Participants will wear an accelerometer for seven days to assess their sedentary and physical
 activity behaviours as well as their sleep.
 
 After this, they will undergo an experimental visit, to asses:
 
 - Fatigue
 
 - Cognitive function
 
 - Tobacco and caffeine consumption
 
 - Fatigue catastrophizing
 
 - Sleep quality
 
 - Sarcopenia risk
 
 - Functional capacities
 
 - Handgrip strength
 
 - Quadriceps maximal strength and fatigability
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06397950
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06397950 through Pure Global AI's free database. This phase not specified trial is sponsored by GCS CIPS and is currently Not yet recruiting. The study focuses on Schizophrenia. Target enrollment is 61 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.